Therapy

October 3, 2017

Seres’ SER-287 for UC Shows Positive Results in Phase 1b Trial

News

Seres Therapeutics announced positive topline results from the company’s Phase 1b placebo-controlled study investigating the effects of SER-287, a potential microbiome therapy, in patients with ulcerative colitis (UC) who failed ... Read more

July 28, 2017January 15, 2020

Crohn’s Disease Health: Mental Effects

Columns, Crohn's Disease, It Could Be Worse - a column by Mary Horsley

Editor’s note: In this series, “Crohn’s Disease Health,” Mary Horsley writes about mental and physical health in relation to IBD, and how unreliable it can be. In the last of ... Read more

July 14, 2015July 14, 2015

Ferring Pharmaceuticals Targeting Inflammatory Bowel Disease With Bacteriophage-based Therapy

IBD News, News

Ferring Pharmaceuticals recently initiated a new research and development collaboration with Intralytix to develop a bacteriophage-based therapy for Inflammatory Bowel Disease (IBD). InflammatoryBowel Disease (IBD) is characterized by chronic inflammation in the digestive ... Read more